Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:01781775n
Noun Concept
SYL
No term available
EN
Regorafenib, sold under the brand name Stivarga among others, is an oral multi-kinase inhibitor developed by Bayer which targets angiogenic, stromal and oncogenic receptor tyrosine kinase. Wikipedia
Relations
Sources
IS A
EN
compound
EN
medicine
MEDICAL CONDITION TREATED
EN
gastrointestinal stromal tumor
EN
rectum cancer
PREGNANCY CATEGORY
EN
Australian pregnancy category D
SUBJECT HAS ROLE
EN
protein kinase inhibitor

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License